Source: ERS Lung Science Conference 2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Karim Vermaelen (Ghent, Belgium). Dendritic cells, immunomodulation, COPD, and cancer. ERS Lung Science Conference 2017

Member's Comments

No comment yet.

Related content which might interest you: Dendritic cells and the immunological homeostasis of the lung Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung Year: 2006 Dendritic cell subsets in the lung: implication for allergic asthma Source: Annual Congress 2006 - A new look at dendritic cell interactions in the lung Year: 2006 Role of dendritic cell subsets in the early stage of cigarette smoke-induced lung inflammation Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Stem cells, their niches, and evolving concepts concerning cancer Source: Annual Congress 2007 - Stem cells and the lung: the road from basics to clinics Year: 2007 Chemokines CXCL12 and CCL21 may contribute to the development of lung cancer in COPD patients Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 The ability of autologous dendritic cells to destroy NSCLC cells in vitro Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Lung dendritic cells and host immunity to infection Source: Eur Respir J 2001; 18: 692-704 Year: 2001 Mast cells in lung disease Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Role of dendritic cells and T-regulatory cells in COPD Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents Year: 2013 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Stem cells and lung cancer Source: Eur Respir Monogr 2021; 91: 340-352 Year: 2021 Characterisation of dendritic cell subsets in lung cancer micro-environments Source: Eur Respir J 2006; 28: 1170-1177 Year: 2006 Expression of PD1, COPD and lung cancer. Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Circulating CD133(+) stem cells in lung cancer patients Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Evidence for cell mediated immune dysfunction in the COPD lung: The role of cytotoxic CD4+ T cells Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Regulatory T, B cells and inflammation: Do they play an important role in lung cancer? Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Lung dendritic cells from chronic obstructive pulmonary disease patients induce type 1 T regulatory cells Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 Epithelial mesenchymal transition (EMT) in the small and large airways of lung cancer patients undergoing thoracotomy Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013